Barclays PLC Aerie Pharmaceuticals Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$6.37 - $15.23 $121,539 - $290,588
19,080 Added 169.81%
30,316 $459,000
Q2 2022

Aug 12, 2022
SELL
$4.95 - $9.16 $50,905 - $94,201
-10,284 Reduced 47.79%
11,236 $85,000
Q1 2022

May 16, 2022
SELL
$5.64 - $9.8 $323,143 - $561,491
-57,295 Reduced 72.7%
21,520 $196,000
Q4 2021

Feb 14, 2022
BUY
$7.02 - $13.33 $247,553 - $470,069
35,264 Added 80.97%
78,815 $553,000
Q3 2021

Nov 09, 2021
BUY
$11.32 - $16.63 $292,214 - $429,286
25,814 Added 145.54%
43,551 $498,000
Q2 2021

Aug 13, 2021
SELL
$15.16 - $18.97 $454,769 - $569,062
-29,998 Reduced 62.84%
17,737 $284,000
Q1 2021

May 13, 2021
SELL
$13.12 - $20.9 $459,147 - $731,416
-34,996 Reduced 42.3%
47,735 $853,000
Q4 2020

Feb 11, 2021
SELL
$9.12 - $14.49 $434,330 - $690,071
-47,624 Reduced 36.53%
82,731 $1.12 Million
Q3 2020

Nov 12, 2020
SELL
$10.46 - $14.46 $497,090 - $687,182
-47,523 Reduced 26.72%
130,355 $1.53 Million
Q2 2020

Aug 12, 2020
BUY
$12.0 - $16.13 $1.76 Million - $2.36 Million
146,603 Added 468.75%
177,878 $2.63 Million
Q1 2020

May 13, 2020
SELL
$11.84 - $25.52 $146,496 - $315,758
-12,373 Reduced 28.35%
31,275 $424,000
Q4 2019

Feb 10, 2020
BUY
$17.72 - $25.1 $235,640 - $333,779
13,298 Added 43.82%
43,648 $1.06 Million
Q3 2019

Nov 14, 2019
SELL
$18.41 - $28.0 $249,805 - $379,932
-13,569 Reduced 30.9%
30,350 $584,000
Q2 2019

Aug 14, 2019
SELL
$28.97 - $48.21 $160,754 - $267,517
-5,549 Reduced 11.22%
43,919 $1.3 Million
Q1 2019

May 15, 2019
BUY
$36.32 - $49.25 $699,595 - $948,653
19,262 Added 63.77%
49,468 $2.35 Million
Q4 2018

Feb 14, 2019
SELL
$33.0 - $60.04 $279,477 - $508,478
-8,469 Reduced 21.9%
30,206 $1.09 Million
Q3 2018

Nov 14, 2018
BUY
$56.15 - $73.9 $1.9 Million - $2.49 Million
33,760 Added 686.88%
38,675 $2.38 Million
Q2 2018

Aug 14, 2018
SELL
$47.85 - $70.45 $485,151 - $714,292
-10,139 Reduced 67.35%
4,915 $332,000
Q1 2018

May 15, 2018
BUY
$51.15 - $61.0 $319,636 - $381,189
6,249 Added 70.97%
15,054 $816,000
Q4 2017

Feb 14, 2018
BUY
$50.85 - $65.1 $157,380 - $201,484
3,095 Added 54.2%
8,805 $527,000
Q3 2017

Nov 14, 2017
BUY
$48.6 - $60.1 $277,506 - $343,171
5,710
5,710 $277,000

Others Institutions Holding AERI

# of Institutions
3
Shares Held
2.4M
Call Options Held
0
Put Options Held
0
View Full List

About AERIE PHARMACEUTICALS INC

AERI Quotes by TradingView
  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email